Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-01-28

Clinical Trial Update: A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and safety study assessing naproxcinod in individuals with impaired renal function to understand exposure and safety in this population…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naproxcinod (naproxcinod)

Snippet

Sponsor: NicOx | Conditions: Renal Failure | Phase 1 | Status: COMPLETED